Research and experimentation tax incentives and international tax issues, including:
Administration's FY 2013 Revenue Proposals,
Tax Reform, including House Ways and Means Discussion Draft Implementation of PL 112-029, the America Invents Act
Trans-Pacific Partnership 12 years of data exclusivity
ITC (International Trade Commission)Patent Reform, no specific bill S.957, The Drug Supply Chain Security Act (Track and Trace)
S.959, The Pharmaceutical Quality Security and Accountability Act (Track and Trace; Compounding)
H.R. 1919, Safeguarding Americas Pharmaceuticals Act of 2013 (Track and Trace)S. 3187, The Food and Drug Safety and Innovation Act (Prescription Drug User Fee Act Reauthorization; Track and Trace)
Biosimilars, no specific bill End Stage Renal Disease and issues related to dialysis
Medicare Part B drug reimbursement issues (Average Sales Price)
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid
11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AMGEN, INC.
601 13th Street, NW, 11th Floor North, WASHINGTON, DC, 20005, US
NANCY ELLEN MCCARTHY (Tax Counsel, Senate Finance Committee) L NICOLE CURRIE VICTORIA BLATTER HELEN RHEE WILLIAM O'BRIEN WILLIAM O'BRIEN HELEN RHEE L NICOLE CURRIE GREGORY PORTNER HELEN RHEE CHAKA BURGESS REBECCA MANDELL HOWARD MOON JESSE KERNS VICTORIA BLATTER WILLIAM O'BRIEN
Tax Counsel, Senate Finance Committee